Restructuring and Other Charges (Tables)

9 Months Ended

Sep. 30, 2011

Restructuring and Other Charges [Abstract]

Schedule of Restructuring and Related Costs

	Three Months Ended September 30,					Nine Months Ended September 30,
	2011			2010		2011		2010
Cost of sales – products	$	630		$	305	$	1,004	$	787
Cost of sales – services		(1,331	)		35		7,298		(175	)
Selling and administrative expense		2,131			100		9,402		2,336
Research, development and engineering expense		7			43		19		(155	)
Total	$	1,437		$	483	$	17,723	$	2,793

Restructuring charges (benefits) within continuing operations for DNA and Diebold International (DI) reporting segments

	Three Months Ended September 30,					Nine Months Ended September 30,
	2011		2010			2011		2010
DNA
Severance	$	391	$	352		$	1,186	$	2,235
Other		220		(98	)		220		(215	)
DI
Severance		781		178			15,230		556
Other (1)		45		51			1,087		217
Total	$	1,437	$	483		$	17,723	$	2,793

(1) Net other restructuring charges in the DI segment include legal fees, accelerated depreciation, facility refurbishment and lease termination costs.

Cumulative total restructuring costs for significant plans

	EMEA Reorganization		Global Workforce Reductions		Global Manufacturing Realignment
Costs incurred to date:
DNA	$	—	$	21,483	$	11,579
DI		14,754		21,452		25,632
Total costs incurred to date	$	14,754	$	42,935	$	37,211

Restructuring accrual balances and related activity

Balance as of January 1, 2011	$	3,340
Liabilities incurred		17,723
Liabilities paid		(13,667	)
Balance as of September 30, 2011	$	7,396